tiprankstipranks
Advertisement
Advertisement

JP:190A Stock Latest News

Chordia Therapeutics Sets Agenda for Q2 FY 2026 Financial and Pipeline Update
Company AnnouncementsChordia Therapeutics Sets Agenda for Q2 FY 2026 Financial and Pipeline Update
1M ago
190A
Chordia Therapeutics Narrows Interim Loss but Maintains Full-Year Red-Ink Forecast
PremiumCompany Announcements
Chordia Therapeutics Narrows Interim Loss but Maintains Full-Year Red-Ink Forecast
1M ago
190A
Chordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort
PremiumCompany Announcements
Chordia Therapeutics Doses First Patient in Rogocekib Expansion Cohort
2M ago
190A
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
PremiumCompany Announcements
Chordia Advances Rogocekib Leukemia Trial With FDA-Aligned Expansion Cohorts
3M ago
190A
Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
PremiumCompany Announcements
Chordia Regains Full Rights to CTX-177 After Ending Ono License Deal
3M ago
190A
Chordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
PremiumCompany AnnouncementsChordia Therapeutics’ Major Shareholder Diluted Below 10% After Warrant Exercises
3M ago
190A
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
Premium
Company Announcements
Chordia Therapeutics Narrows Quarterly Loss but Forecasts Continued Full-Year Red Ink
4M ago
190A
Chordia Therapeutics to Record Grant Income in Fiscal Year 2026
Premium
Company Announcements
Chordia Therapeutics to Record Grant Income in Fiscal Year 2026
6M ago
190A
Chordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment
PremiumCompany Announcements
Chordia Therapeutics’ CTX-712 Study: A Potential Breakthrough in AML and HR-MDS Treatment
7M ago
190A
Chordia Therapeutics Restructures Capital to Strengthen Financial Foundation
PremiumCompany Announcements
Chordia Therapeutics Restructures Capital to Strengthen Financial Foundation
7M ago
190A
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
PremiumCompany Announcements
Chordia Therapeutics Reports Fiscal Year 2025 Financial Results
7M ago
190A
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
PremiumCompany Announcements
Chordia Therapeutics Reports Continued Losses in Latest Financial Results
10M ago
190A
Chordia Therapeutics Secures Grant for Cancer Therapy Research
PremiumCompany AnnouncementsChordia Therapeutics Secures Grant for Cancer Therapy Research
11M ago
190A
Chordia Therapeutics Announces Change in Major Shareholder
Premium
Company Announcements
Chordia Therapeutics Announces Change in Major Shareholder
1y ago
190A
Chordia Therapeutics Regains Rights to CTX-177 as Ono Discontinues Development
Premium
Company Announcements
Chordia Therapeutics Regains Rights to CTX-177 as Ono Discontinues Development
1y ago
190A
Chordia Therapeutics Reports Financial Losses for Six-Month Period Ending February 2025
PremiumCompany Announcements
Chordia Therapeutics Reports Financial Losses for Six-Month Period Ending February 2025
1y ago
190A
Chordia Therapeutics Secures Orphan Drug Designation for Rogocekib in the U.S.
PremiumCompany Announcements
Chordia Therapeutics Secures Orphan Drug Designation for Rogocekib in the U.S.
1y ago
190A
Chordia Therapeutics Unveils New Research Insights
PremiumCompany Announcements
Chordia Therapeutics Unveils New Research Insights
1y ago
190A
Chordia Therapeutics Focuses on Innovative Drug Development
PremiumCompany Announcements
Chordia Therapeutics Focuses on Innovative Drug Development
1y ago
190A
Chordia Therapeutics Advances Cancer Drug Development
PremiumCompany AnnouncementsChordia Therapeutics Advances Cancer Drug Development
1y ago
190A
Chordia Therapeutics Enhances Transparency with Earnings Transcript
Premium
Company Announcements
Chordia Therapeutics Enhances Transparency with Earnings Transcript
2y ago
190A
Chordia Therapeutics’ Successful CTX-712 Trial Results
Premium
Company Announcements
Chordia Therapeutics’ Successful CTX-712 Trial Results
2y ago
190A

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >